Search results
Author(s):
Carolyn M Webb
,
Peter Collins
Added:
3 years ago
Cardiovascular disease (CVD) is the most prevalent non-communicable cause of death worldwide.1 The health and economic implications of caring for a growing ageing population with CVD is enormous. Maintaining a “healthy” elderly population that is mobile and independent with a good quality of life is vital. Testosterone is a sex hormone that is predominant in males, being secreted from the testes…
View more
Author(s):
Joakim Alfredsson
,
Eva Swahn
Added:
3 years ago
Cardiovascular diseases are the leading cause of death in industrialised countries; among these, coronary artery disease (CAD) is the most prevalent and is associated not only with high mortality but also with substantial morbidity. Acute manifestations of CAD are ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), unstable angina pectoris (UAP) and sudden ischaemic death.1 Due to the…
View more
AS Grading in Women
Author(s):
Dana Cramariuc
,
Edda Bahlmann
,
Eva Gerdts
Added:
1 year ago
Article
Author(s):
Eva Gerdts
,
Giovanni de Simone
Added:
2 years ago
Author(s):
Rachel Lampert
Added:
3 years ago
The increased risk of drug-related torsades de pointes (TdP) and death in women taking ion-channel-active antiarrhythmic drugs was first described 20 years ago. In 1993, Makkar1 identified all case reports or case series of drug-related TdP, finding 332 patients described in 83 articles. The proportion of women versus men in these reported series was compared with the proportion of women versus…
View more
Sex, Drugs, MVD, rSS and STEMI
Author(s):
Sonya Burgess
,
Craig P Juergens
,
Wesley Yang
,
et al
Added:
1 year ago
Article
Testosterone and the Heart
Author(s):
Michael G Kirby
,
Geoffrey Hackett
,
Sudarshan Ramachandran
Added:
3 years ago
Article
Author(s):
Heather Currie
,
Christine Williams
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death in both men and women, yet the extent of the problem in women is frequently underestimated and, compared with men, women are less likely to be offered interventions, are less likely to be represented in clinical trials and have a worse prognosis. This article aims to examine the extent of the problem of CVD in women, summarise the…
View more
Author(s):
Nina Rashedi
,
Catherine M Otto
Added:
1 year ago
Author(s):
Gurpreet K Singh
,
Victoria Delgado
Added:
1 year ago